Pfizer (PFE)

43.80 -0.77 (1.73%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (1/30/19 *Est.)

Latest Headlines

Pfizer (PFE) Raises Quarterly Dividend 5.9% to $0.36, 3.3% Yield; Authorizes New $10B Buyback December 14, 2018 12:11 PM - StreetInsider Pfizer Declares First-Quarter 2019 Dividend December 14, 2018 12:10 PM - BizWire Pfizer (PFE) Receives Positive CHMP Opinion for Oncology Biosimilar, ZIRABEV December 14, 2018 10:29 AM - StreetInsider Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, ZIRABEV™ (bevacizumab) December 14, 2018 10:29 AM - BizWire Pfizer (PFE) Commences Phase 3 Program for 20-Valent Pneumococcal Conjugate Vaccine (20vPnC) Candidate, PF-06482077 December 14, 2018 8:01 AM - StreetInsider Pfizer Initiates Phase 3 Program for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older December 14, 2018 8:00 AM - BizWire Merck bolsters animal health unit with $2.4 billion Antelliq purchase December 14, 2018 7:05 AM - StreetInsider BMO Capital Reiterates Market Perform on Pfizer (PFE) Following Investor Meetings December 13, 2018 7:34 AM - StreetInsider JPMorgan Downgrades Pfizer (PFE) to Neutral December 11, 2018 5:05 AM - StreetInsider Exclusive: Activist investor Elliott has stake in Germany's Bayer - sources December 7, 2018 11:22 AM - StreetInsider Form 8-K PFIZER INC For: Dec 07 December 7, 2018 6:46 AM - SEC Filing Form 4 PFIZER INC For: Nov 30 Filed by: YOUNG JOHN D December 4, 2018 7:15 AM - SEC Filing Form 4 PFIZER INC For: Nov 30 Filed by: ROGERS DAWN December 4, 2018 7:15 AM - SEC Filing Form 4 PFIZER INC For: Nov 30 Filed by: JOHNSON RADY A December 4, 2018 7:15 AM - SEC Filing Form 4 PFIZER INC For: Nov 30 Filed by: BOURLA ALBERT December 4, 2018 7:15 AM - SEC Filing Pfizer Presents Positive 26-Week Data For PF-05280586, A Potential Biosimilar To Rituximab, At The American Society Of Hematology Annual Meeting December 2, 2018 3:45 PM - BizWire Pfizer (PFE) call put ratio 7.8 calls to 1 put with focus on January 46 and 48 calls November 30, 2018 12:39 PM - StreetInsider Pfizer (PFE) Reaches Global Agreement with AbbVie (ABBV) on Adalimumab Biosimilar November 30, 2018 10:01 AM - StreetInsider Pfizer Reaches a Global Agreement with AbbVie November 30, 2018 10:00 AM - BizWire Bayer to sell businesses, cut jobs after Monsanto deal November 29, 2018 9:06 AM - StreetInsider Pfizer (PFE) Granted Six Months Pediatric Exclusivity for LYRICA November 27, 2018 3:02 PM - StreetInsider Pfizer Receives Six Months Pediatric Exclusivity for LYRICA® (pregabalin) November 27, 2018 3:01 PM - BizWire Aileron Therapeutics (ALRN) Announces Clinical Trial Collaboration with Pfizer (PFE) to Evaluate ALRN-6924 in Combination with IBRANCE (palbociclib) in MDM2-Amplified Cancers November 27, 2018 8:05 AM - StreetInsider Pfizer (PFE) Announces FDA Approval of DAURISMO November 21, 2018 1:42 PM - StreetInsider U.S. FDA Approves DAURISMO™ (glasdegib) for Adult Patients with Newly-Diagnosed Acute Myeloid Leukemia (AML) for Whom Intensive Chemotherapy is Not an Option November 21, 2018 1:40 PM - BizWire Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference November 21, 2018 10:00 AM - BizWire BioMarin sets stage early for hemophilia cure off-Broadway November 21, 2018 1:13 AM - StreetInsider Pfizer (PFE) and Merck KGaA, Darmstadt, Germany Report Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer November 19, 2018 7:23 AM - StreetInsider Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer November 19, 2018 7:14 AM - PR NewsWire Form 4 PFIZER INC For: Nov 15 Filed by: YOUNG JOHN D November 16, 2018 6:42 PM - SEC Filing Form 4 PFIZER INC For: Nov 15 Filed by: JOHNSON RADY A November 16, 2018 6:41 PM - SEC Filing Form 4 PFIZER INC For: Nov 15 Filed by: ROGERS DAWN November 16, 2018 6:41 PM - SEC Filing Form 4 PFIZER INC For: Nov 15 Filed by: BOURLA ALBERT November 16, 2018 6:41 PM - SEC Filing UPDATE: Pfizer (PFE) to Raise List Prices of 10% of Drugs in Jan - DJ November 16, 2018 2:51 PM - StreetInsider Walmart, Home Depot adopt health insurer tactic in drug copay battle November 13, 2018 7:32 AM - StreetInsider Form 10-Q PFIZER INC For: Sep 30 November 8, 2018 4:46 PM - SEC Filing Health stocks up on U.S. vote; insurers hit records November 7, 2018 4:16 AM - StreetInsider Form 4 PFIZER INC For: Nov 02 Filed by: READ IAN C November 6, 2018 3:47 PM - SEC Filing Nektar Therapeutics (NKTR), Pfizer (PBE) Enter Pact to Evaluate Combination of NKTR-214 with Avelumab and Talazoparib or Enzalutamide in Multiple Cancers November 6, 2018 8:34 AM - StreetInsider New Clinical Oncology Collaboration Between Nektar and Pfizer to Evaluate Combination of NKTR-214, a CD122-Biased Agonist, with Avelumab and Talazoparib or Enzalutamide in Multiple Cancers November 6, 2018 8:30 AM - PR NewsWire Pfizer (PFE) PT Raised to $37 at Citi November 6, 2018 7:17 AM - StreetInsider Takeda CEO confident of investor backing for $62 billion Shire deal November 5, 2018 10:05 AM - StreetInsider U.S. FDA Approves LORBRENA® (lorlatinib) for Previously-Treated ALK-Positive Metastatic NSCLC November 2, 2018 4:42 PM - BizWire Pfizer's (PFE) Lorlatinib Receives FDA Approval November 2, 2018 3:48 PM - StreetInsider Form 4 PFIZER INC For: Oct 31 Filed by: YOUNG JOHN D November 1, 2018 7:40 PM - SEC Filing Form 4 PFIZER INC For: Oct 31 Filed by: JOHNSON RADY A November 1, 2018 7:40 PM - SEC Filing Form 4 PFIZER INC For: Oct 31 Filed by: ROGERS DAWN November 1, 2018 7:40 PM - SEC Filing Form 4 PFIZER INC For: Oct 31 Filed by: BOURLA ALBERT November 1, 2018 7:40 PM - SEC Filing Pfizer (PFE) said to Weigh Sale of $2B Women's Health Portfolio - Bloomberg November 1, 2018 8:42 AM - StreetInsider BMO Capital Downgrades Pfizer (PFE) to Market Perform November 1, 2018 4:17 AM - StreetInsider Pfizer (PFE) PT Raised to $43 at Societe Generale November 1, 2018 3:11 AM - StreetInsider Pfizer (PFE) PT Raised to $42 at Credit Suisse October 31, 2018 8:56 AM - StreetInsider Pre-Open Movers 10/30: (ESIO) (UAA) (TTWO) Higher; (ELVT) (CHK) (TXRH) Lower (more...) October 30, 2018 9:19 AM - StreetInsider Form 8-K PFIZER INC For: Oct 30 October 30, 2018 8:39 AM - SEC Filing Pfizer revenue worse than expected as generic competition weighs October 30, 2018 6:55 AM - StreetInsider Pfizer (PFE) Tops Q3 EPS by 3c October 30, 2018 6:47 AM - StreetInsider PFIZER REPORTS THIRD-QUARTER 2018 RESULTS October 30, 2018 6:45 AM - BizWire Autos and banks help European shares rebound after sell-off October 29, 2018 4:45 AM - StreetInsider Pfizer Announces Clinical Development Agreement with Novartis to Advance the Treatment of NASH October 29, 2018 2:15 AM - BizWire Merck, Bristol-Myers profits rise on cancer drug sales October 25, 2018 10:43 AM - StreetInsider Pfizer (PFE), Eli Lilly and Co. (LLY) Report Complete Results from Phase 3 Study of Tanezumab Showing Significant Improvement in Pain & Function in Osteoarthritis Patients October 24, 2018 5:51 AM - StreetInsider Complete Results from First Study in Ongoing Phase 3 Program for Tanezumab Demonstrated Significant Improvement in Pain and Function in Osteoarthritis Patients October 23, 2018 6:40 PM - BizWire Wolfe Research Starts Pfizer (PFE) at Peerperform October 23, 2018 9:36 AM - StreetInsider Bain Capital and Pfizer (PFE) Create Cerevel Therapeutics October 23, 2018 8:40 AM - StreetInsider Bain Capital and Pfizer Create Cerevel Therapeutics, New CNS Company October 23, 2018 8:30 AM - BizWire Pfizer (PFE) Reports OS Data from PALOMA-3 Trial of IBRANCE (palbociclib) in Patients With HR+, HER2- Metastatic Breast Cancer October 22, 2018 6:09 AM - StreetInsider Pfizer Presents Overall Survival Data From PALOMA-3 Trial of IBRANCE® (palbociclib) in Patients With HR+, HER2- Metastatic Breast Cancer October 20, 2018 10:30 AM - BizWire Merck (MRK) Reports Significant Improved OS & PFS Data from Pivotal Phase 3 KEYNOTE-426 Trial Investigating KEYTRUDA (pembrolizumab) in Combination with Pfizer’s (PFE) Inlyta (axitinib) October 18, 2018 7:01 AM - StreetInsider Pfizer to cut around 2 percent of jobs through early next year October 17, 2018 1:02 PM - StreetInsider Pfizer (PFE) offers early retirement ahead of layoffs in memo to employees - CNBC October 17, 2018 11:22 AM - StreetInsider Pfizer (PFE) PT Raised to $53 at Cantor Fitzgerald October 17, 2018 9:06 AM - StreetInsider Form 4 PFIZER INC For: Oct 15 Filed by: YOUNG JOHN D October 16, 2018 6:44 PM - SEC Filing Form 4 PFIZER INC For: Oct 15 Filed by: ROGERS DAWN October 16, 2018 6:44 PM - SEC Filing Form 4 PFIZER INC For: Oct 15 Filed by: JOHNSON RADY A October 16, 2018 6:44 PM - SEC Filing Form 4 PFIZER INC For: Oct 15 Filed by: BOURLA ALBERT October 16, 2018 6:44 PM - SEC Filing BioMarin Pharma (BMRN) Announces $15M Milestone Payment from Pfizer (PFE) October 16, 2018 12:59 PM - StreetInsider FDA approves Pfizer's (PFE) talazoparib for gBRCAm HER2-negative locally advanced or metastatic breast cancer October 16, 2018 11:28 AM - StreetInsider U.S. to propose TV ads for drugs must include list prices October 15, 2018 1:37 PM - StreetInsider Form 4 PFIZER INC For: Oct 09 Filed by: YOUNG JOHN D October 10, 2018 5:48 PM - SEC Filing Form 4 PFIZER INC For: Oct 09 Filed by: JOHNSON RADY A October 10, 2018 5:47 PM - SEC Filing Form 4 PFIZER INC For: Oct 09 Filed by: ROGERS DAWN October 10, 2018 5:47 PM - SEC Filing Form 4 PFIZER INC For: Oct 09 Filed by: BOURLA ALBERT October 10, 2018 5:47 PM - SEC Filing Increasing unusual option volume: PFE NIO CCK GE IMPV ACRX ITT FAST ACHC EWH ESPR NIO October 10, 2018 11:42 AM - StreetInsider Pfizer Announces Executive Leadership Team October 9, 2018 9:05 AM - BizWire Myriad Genetics (MYGN) announces it signed commercialization plan with Pfizer (PFE) October 9, 2018 7:15 AM - StreetInsider Stada, buyout funds in race for Bristol-Myers' French business: sources October 8, 2018 9:16 AM - StreetInsider Form 4 PFIZER INC For: Sep 28 Filed by: JOHNSON RADY A October 1, 2018 5:32 PM - SEC Filing Form 4 PFIZER INC For: Sep 28 Filed by: YOUNG JOHN D October 1, 2018 5:32 PM - SEC Filing Form 4 PFIZER INC For: Sep 28 Filed by: ROGERS DAWN October 1, 2018 5:32 PM - SEC Filing Form 4 PFIZER INC For: Sep 28 Filed by: BOURLA ALBERT October 1, 2018 5:32 PM - SEC Filing Form 8-K PFIZER INC For: Sep 27 October 1, 2018 4:55 PM - SEC Filing Form 4 PFIZER INC For: Sep 28 Filed by: NARAYEN SHANTANU October 1, 2018 4:21 PM - SEC Filing Form 4 PFIZER INC For: Sep 28 Filed by: SMITH JAMES C October 1, 2018 4:21 PM - SEC Filing Form 4 PFIZER INC For: Sep 28 Filed by: KILTS JAMES M October 1, 2018 4:21 PM - SEC Filing Form 4 PFIZER INC For: Sep 28 Filed by: Echevarria Joseph October 1, 2018 4:21 PM - SEC Filing Pfizer to replace longtime CEO Read with veteran Bourla October 1, 2018 6:51 AM - StreetInsider Pfizer (PFE) Elected Dr. Albert Bourla to Succeed Ian Read as CEO Effective January 1; Ian Read will Transition to Executive Chairman October 1, 2018 6:46 AM - StreetInsider Pfizer Announces CEO Succession October 1, 2018 6:45 AM - BizWire Pfizer (PFE) COO Albert Bourla to become CEO; Read to shift to Executive Chairman - WSJ October 1, 2018 6:40 AM - StreetInsider Scientists behind game-changing cancer immunotherapies win Nobel medicine prize October 1, 2018 5:43 AM - StreetInsider Pfizer (PFE) Announces U.S. FDA Approval of VIZIMPRO for First-Line Treatment of Patients with EGFR-Mutated Metastatic NSCLC September 27, 2018 5:42 PM - StreetInsider U.S. FDA Approves VIZIMPRO® (dacomitinib) for the First-Line Treatment of Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer September 27, 2018 5:41 PM - BizWire Pfizer (PFE) Declares $0.34 Quarterly Dividend; 3.1% Yield September 27, 2018 1:12 PM - StreetInsider Pfizer Declares 34-Cent Fourth-Quarter 2018 Dividend September 27, 2018 1:09 PM - BizWire Amarin Corp. (AMRN) Ticks Higher on Renewed Takeover Chateter September 27, 2018 9:42 AM - StreetInsider Pfizer AA Data is a Positive Read Through to CTP-543 - Mizuho (PFE) (CNCE) September 24, 2018 9:17 AM - StreetInsider Astellas Receives Positive CHMP Opinion for XTANDI® (enzalutamide) for Adult Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer September 24, 2018 9:00 AM - PR NewsWire Sarepta Therapeutics (SRPT) and Pfizer (PFE) Could Make Headlines At The World Muscle Society Conference - Nomura September 24, 2018 6:27 AM - StreetInsider Animal health firm Elanco surges 41 percent on debut September 20, 2018 11:41 AM - StreetInsider Pfizer (PFE) Granted FDA Breakthrough Therapy Designation for 20-Valent Pneumococcal Conjugate Vaccine for Prevention of Invasive Disease and Pneumonia in Adults September 20, 2018 8:05 AM - StreetInsider Pfizer Granted FDA Breakthrough Therapy Designation for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older September 20, 2018 8:00 AM - BizWire Pfizer Invites Public to View and Listen to Webcast of October 30 Conference Call with Analysts September 19, 2018 4:26 PM - BizWire New Sub-group Analyses from the Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) Study Presented at 2018 HFSA Annual Scientific Meeting September 19, 2018 4:26 PM - BizWire New Sub-group Analyses from the Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) Study Presented at 2018 HFSA Annual Scientific Meeting September 18, 2018 2:45 PM - BizWire Pfizer Invites Public to View and Listen to Webcast of October 30 Conference Call with Analysts September 18, 2018 10:00 AM - BizWire Pfizer (PFE) Says New Sub-group Analyses from Tafamidis Phase 3 ATTR-ACT Study Presented at HFSA September 18, 2018 9:04 AM - StreetInsider New Sub-group Analyses from the Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy (ATTR-ACT) Study Presented at 2018 HFSA Annual Scientific Meeting September 18, 2018 9:01 AM - BizWire Form 4 PFIZER INC For: Sep 13 Filed by: Dolsten Mikael September 17, 2018 4:13 PM - SEC Filing Form 4 PFIZER INC For: Sep 14 Filed by: YOUNG JOHN D September 17, 2018 4:12 PM - SEC Filing Form 4 PFIZER INC For: Sep 14 Filed by: JOHNSON RADY A September 17, 2018 4:12 PM - SEC Filing Form 4 PFIZER INC For: Sep 14 Filed by: BOURLA ALBERT September 17, 2018 4:11 PM - SEC Filing Form 4 PFIZER INC For: Sep 14 Filed by: ROGERS DAWN September 17, 2018 4:11 PM - SEC Filing Pfizer (PFE) Announces Evaluation Agreement with Atomwise Inc. September 17, 2018 8:10 AM - StreetInsider Atomwise Enters Into an Evaluation Agreement with Pfizer September 17, 2018 8:01 AM - BizWire Pfizer (PFE) Announces Positive Phase 2 Data in Alopecia Areata at 2018 EADV Congress September 17, 2018 5:50 AM - StreetInsider Full Article List